abstract |
A non-exclusive aspect provides molecules further improved from antibodies capable of binding antigens in an ion concentration-dependent manner. Alternative non-exclusive aspects provide safe and more favorable Fc region variants with reduced binding to pre-existing ADA. Alternative non-exclusive aspects provide novel IL-8 antibodies that are excellent as drugs. |